Clinical trial
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
NCT00303446 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00303446 |
|---|---|
| Title | Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) |
| Official title | Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients With Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kennedy's Disease, Spinal and Bulbar Muscular Atrophy |
| Intervention type | Drug |
| Interventions | Dutasteride, Placebo |
| Enrollment | 57 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Mar 16, 2006 |
| Last update posted | Jan 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: